Does metoprolol lower blood sugar
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Metoprolol on Blood Sugar Levels
Metoprolol and Blood Glucose Levels
Metoprolol, a cardioselective beta-blocker, is commonly prescribed for managing hypertension and heart conditions. However, its effects on blood glucose levels have been a subject of research, with varying outcomes reported.
Metoprolol and Insulin Sensitivity
Several studies have investigated the impact of metoprolol on insulin sensitivity and glucose metabolism. A randomized, double-blind study comparing metoprolol and atenolol found that both drugs caused a small increase in fasting plasma insulin and blood glucose concentrations. This study also noted a decrease in glucose uptake mediated by insulin, indicating reduced insulin sensitivity during metoprolol treatment. Another study observed that metoprolol did not significantly affect glucose homeostasis in hypertensive diabetic subjects, suggesting that the drug's impact might vary depending on the patient population.
Metoprolol and Hyperglycemia
Research has also highlighted the potential for metoprolol to induce hyperglycemia. A study on patients with diastolic hypertension reported that while metoprolol effectively reduced blood pressure, it also led to an increase in fasting blood glucose and postprandial blood glucose levels over a 24-month period. This finding underscores the need for careful monitoring of blood glucose levels in patients undergoing long-term metoprolol therapy.
Comparative Studies with Other Beta-Blockers
Comparative studies have provided additional insights into metoprolol's effects on blood glucose. For instance, a trial comparing metoprolol, propranolol, and acebutolol found that both metoprolol and propranolol potentiated insulin-induced hypoglycemia and delayed the return to normoglycemia, whereas acebutolol did not significantly delay recovery. Another large-scale study, the Carvedilol Or Metoprolol European Trial (COMET), revealed that new onset diabetes was more likely to occur in patients treated with metoprolol compared to those treated with carvedilol.
Glucose Tolerance and Insulin Release
Further research into glucose tolerance and insulin release in hypertensive patients treated with metoprolol showed no significant changes in fasting blood glucose or plasma insulin levels. Additionally, the blood glucose response following an intravenous or oral glucose load remained unaffected by metoprolol treatment. These findings suggest that while metoprolol may influence insulin sensitivity, its impact on glucose tolerance and insulin release might be minimal in certain patient groups.
Conclusion
In summary, metoprolol has been shown to affect blood glucose levels and insulin sensitivity in various ways. While some studies report an increase in blood glucose and reduced insulin sensitivity, others find minimal impact on glucose homeostasis. The potential for metoprolol to induce hyperglycemia and new onset diabetes highlights the importance of monitoring blood glucose levels in patients undergoing treatment. Further research is needed to fully understand the mechanisms and patient-specific factors influencing these outcomes.
Sources and full results
Most relevant research papers on this topic